Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 308-315

  Dejana, E ^a   Spagnuolo, R ^a   Bazzoni, G ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Adherens and tight junctions; Angiogenesis; Endothelium; Inflammation; Permeability

Indexed keywords

ANGIOGENESIS INHIBITOR; CADHERIN; CATENIN; CELL ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE A; UNCLASSIFIED DRUG;

ANGIOGENESIS; BINDING KINETICS; BLOOD VESSEL FUNCTION; BLOOD VESSEL PERMEABILITY; CELL FUNCTION; CELL INFILTRATION; CELL INTERACTION; CELL SPECIFICITY; CONFERENCE PAPER; DRUG TARGETING; ENDOTHELIUM; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HEMOSTASIS; HUMAN; INHIBITION KINETICS; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MEMBRANE STRUCTURE; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0034912203     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616228     Document Type: Conference Paper

References (89)

1. Interendothelial junctions: Structure, signalling and functional roles
2. Endothelial adhesion molecules in the development of vascular tree: The garden of forking paths
3. Endothelial cell-to-cell junctions
4. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
5. Regulation of cadherin adhesive activity
6. Structural basis of cell-cell adhesion by cadherins
7. Cadherins. A molecular family important in selective cell-cell adhesion
8. Cadherin-catenin complex: Protein interactions and their implications for cadherin function
9. Molecular structure and functional role of vascular tight junctions
10. Structural and signalling molecules come together at tight junctions
11. Carcinongenesis: A balance between beta-catenin and APC
12. Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis
13. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
14. Breaking through the tight junction barrier
15. Molecular architecture of tight junctions
16. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein
17. Occludin: A novel integral membrane protein localizing at tightj unctions
18. A dominant mutant of occludin disrupts tight junction structure and function
19. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions
20. Complex phenotype of mice lacking occludin, a component of tight junction strands
21. Occludin and claudins in tight-junction strands: Leading or supporting players?
22. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts
23. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration
24. The biology of PECAM-1
25. Identification of the S-Endo 1 endothelial-associated antigen
26. Characterization of MEC 14.7, a new monoclonal antibody recognizing mouse CD34: A useful reage for identifying and characterizing blood vessels and hematopoietic precursor
27. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line
28. Identification of a novel cadherin (vascular endothelial cadherin-2) located at intracellular junctions in endothelial cells
29. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular systems
30. Genomic structure and chromosomal mapping of the mouse VE-cadherin gene (Cdh5)
31. The VE-cadherin promotor directs endothelial-specific expression in transgenic mice
32. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?
33. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+cells at a diverging point endothelial and hemopoietic lineages
34. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5) an endothelial specific cadherin
35. Cadherin in cancer: Implications for invasion and metastasis
36. Catenin-dependent and -independent functions of vascular endothelial cadherin
37. The membrane-proximal region of the E-cadherin cytoplasmic domain prevents dimerization and negatively adhesion activity
38. The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adherive strengthening, and interaction with p120ctn
39. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells
40. Inhibition of RhoA by p120 catenin
41. Identification of a new catenin: The tyrosine kinase substrate p120cas associates with E-cadherin complexes
42. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin)
43. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line
44. The molecular organization of endothelial cell to cell junctions: Differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin)
45. A versatile transcriptional effector of Wingless signaling
46. Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer
47. The role of beta-cadenin in cell adhesion, signal transduction, and cancer
48. Plakoglobin and beta-catenin: Protein interactions, regulation and biological roles
49. The oncogenic activation of beta-catenin
50. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
51. A role of cadherins in tissue formation
52. Direct involvement of N-cadherin-mediated signaling in muscle differentiation
53. N-cadherin extracellular repear 4 mediates epithelial to mesenchymal transition and increased mobility
54. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies
55. Developmental defects in mouse embryos lacking N-cadherin
56. Beta-Catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
57. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo
58. VE-cadherin antibody accelerates neutrophil recruitment in vivo
59. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization
60. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions
61. Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules
62. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin
63. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to Junctional Adhesion Molecule (JAM)
64. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow
65. VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels
66. Endothelial cell VE-cadherin functions as a receptor for the beta 15-42 sequence of fibrin
67. Monoclonal antibody to vascular endothelial (VE)-cadherin is a potent inhibitor of angiogenesis, tumor growth and metastasis
68. Human junction adhesion molecule regulates tight junction resealing in epithelia
69. Characterization of huJAM: Evidence for involvement in cell-cell contact and tight junction regulation
70. A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets
71. Combined treatment of TNF-alpha and IFN-gamma causes of redistribution of junctional adhesion molecule in human endothelial cells
72. Identification and characterisation of human junctional adhesion molecule (JAM)
73. Cloning of the human platelet F11 receptor: A cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation
74. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells
75. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells
76. A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions
77. CTX, a xenopus thymocyte receptor, defines a molecular family conserved throughout vertebrates
78. Cloning of JAM-2 and JAM-3: An emerging junctional adhesion molecular family?
79. Hemophilic interaction of junctional adhesion molecule
80. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains
81. Protein modules as organizers of membrane structure
82. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and Zo-3, with the COOH termini of claudins
83. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tigth junction
84. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin
85. Cingulin contains glomerular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin
86. Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial Caco-2 cells
87. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1
88. Absence of the tight junctional protein AF-6 disrupts epithelial cell-cell junctions and cell polarity during mouse development
89. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation